Proceedings of the American Thoracic Society Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


The Proceedings of the American Thoracic Society 3:594-600 (2006)
© 2006 The American Thoracic Society
doi: 10.1513/pats.200605-115LR

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bresser, P.
Right arrow Articles by Hoeper, M. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bresser, P.
Right arrow Articles by Hoeper, M. M.

Medical Therapies for Chronic Thromboembolic Pulmonary Hypertension

An Evolving Treatment Paradigm

Paul Bresser, Joanna Pepke-Zaba, Xavier Jaïs, Marc Humbert and Marius M. Hoeper

Department of Pulmonology, Academic Medical Center, University of Amsterdam, The Netherlands; Pulmonary Vascular Disease Unit, Papworth Hospital, Cambridge, United Kingdom; Hôpital Antoine Béclère, Clamart, France; and Department of Respiratory Medicine, Hannover Medical School, Hannover, Germany

Correspondence and requests for reprints should be addressed to Paul Bresser, M.D., Department of Pulmonology, Academic Medical Center (AMC), P.O. Box 22660, Amsterdam 1100 DD, The Netherlands. E-mail: p.bresser{at}amc.uva.nl

ABSTRACT

Pulmonary endarterectomy (PEA) is recommended as the treatment of choice for eligible patients with chronic thromboembolic pulmonary hypertension (CTEPH). However, only a proportion of patients fulfill the criteria for surgical intervention. In addition, operated patients with CTEPH may experience a gradual hemodynamic and symptomatic decline related to a secondary hypertensive arteriopathy in the small precapillary pulmonary vessels. It has also been questioned what can be done to reduce risks from PEA surgery to improve outcome in "high risk" patients with CTEPH with substantial impairment of pulmonary hemodynamics before surgery. Such patients may benefit from preoperative reduction of pulmonary vascular resistance by means of medical therapy. Conventional medical treatments, such as anticoagulation, diuretics, digitalis, and chronic oxygen therapy, show low efficacy in the treatment of CTEPH as they do not affect underlying disease processes. Over the last decade, several novel therapies have been developed for pulmonary arterial hypertension (PAH), including prostacyclin analogs (epoprostenol, beraprost, iloprost), endothelin receptor antagonists (bosentan, sitaxsentan, ambrisentan), and phosphodiesterase-5 inhibitors (sildenafil). Evidence of efficacy in PAH, coupled with studies showing histopathologic similarities between CTEPH and PAH, provides a rationale to extend the use of some of these medications to the treatment of CTEPH. However, direct evidence from clinical trials in CTEPH is limited to date. This article reviews evidence supporting, and issues surrounding, the possible use of novel PAH medications in CTEPH.

Key Words: bosentan • pharmacotherapy • prostanoid • pulmonary arterial hypertension • thromboembolic




This article has been cited by other articles:


Home page
J Am Coll CardiolHome page
A. M. Keogh, E. Mayer, R. L. Benza, P. Corris, P. G. Dartevelle, A. E. Frost, N. H. Kim, I. M. Lang, J. Pepke-Zaba, and J. Sandoval
Interventional and surgical modalities of treatment in pulmonary hypertension.
J. Am. Coll. Cardiol., June 30, 2009; 54(1 Suppl): S67 - S77.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
V. V. McLaughlin, S. L. Archer, D. B. Badesch, R. J. Barst, H. W. Farber, J. R. Lindner, M. A. Mathier, M. D. McGoon, M. H. Park, R. S. Rosenson, et al.
ACCF/AHA 2009 Expert Consensus Document on Pulmonary Hypertension: A Report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association Developed in Collaboration With the American College of Chest Physicians; American Thoracic Society, Inc.; and the Pulmonary Hypertension Association
J. Am. Coll. Cardiol., April 28, 2009; 53(17): 1573 - 1619.
[Full Text] [PDF]


Home page
CirculationHome page
Writing Committee Members, V. V. McLaughlin, S. L. Archer, D. B. Badesch, R. J. Barst, H. W. Farber, J. R. Lindner, M. A. Mathier, M. D. McGoon, M. H. Park, et al.
ACCF/AHA 2009 Expert Consensus Document on Pulmonary Hypertension: A Report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association: Developed in Collaboration With the American College of Chest Physicians, American Thoracic Society, Inc., and the Pulmonary Hypertension Association
Circulation, April 28, 2009; 119(16): 2250 - 2294.
[Full Text] [PDF]


Home page
ERRHome page
I. M. Lang
Managing chronic thromboembolic pulmonary hypertension: pharmacological treatment options
Eur. Respir. Rev., March 1, 2009; 18(111): 24 - 28.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
N. Skoro-Sajer, N. Hack, R. Sadushi-Kolici, D. Bonderman, J. Jakowitsch, W. Klepetko, M. A. R. Hoda, M. P. Kneussl, P. Fedullo, and I. M. Lang
Pulmonary Vascular Reactivity and Prognosis in Patients With Chronic Thromboembolic Pulmonary Hypertension: A Pilot Study
Circulation, January 20, 2009; 119(2): 298 - 305.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
S. Rich and M. Rabinovitch
Diagnosis and Treatment of Secondary (Non-Category 1) Pulmonary Hypertension
Circulation, November 18, 2008; 118(21): 2190 - 2199.
[Full Text] [PDF]


Home page
ChestHome page
N. S. Hill, I. R. Preston, and K. E. Roberts
Inoperable Chronic Thromboembolic Pulmonary Hypertension: Treatable With Medical Therapy
Chest, August 1, 2008; 134(2): 221 - 223.
[Full Text] [PDF]


Home page
ChestHome page
J. Suntharalingam, C. M. Treacy, N. J. Doughty, K. Goldsmith, E. Soon, M. R. Toshner, K. K. Sheares, R. Hughes, N. W. Morrell, and J. Pepke-Zaba
Long-term Use of Sildenafil in Inoperable Chronic Thromboembolic Pulmonary Hypertension
Chest, August 1, 2008; 134(2): 229 - 236.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
C. Kearon, S. R. Kahn, G. Agnelli, S. Goldhaber, G. E. Raskob, and A. J. Comerota
Antithrombotic Therapy for Venous Thromboembolic Disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)
Chest, June 1, 2008; 133(6_suppl): 454S - 545S.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
R. Condliffe, D. G. Kiely, J. S. R. Gibbs, P. A. Corris, A. J. Peacock, D. P. Jenkins, D. Hodgkins, K. Goldsmith, R. J. Hughes, K. Sheares, et al.
Improved Outcomes in Medically and Surgically Treated Chronic Thromboembolic Pulmonary Hypertension
Am. J. Respir. Crit. Care Med., May 15, 2008; 177(10): 1122 - 1127.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
S. E. Orfanos and S. Zakynthinos
Heart biomarkers as prognostic tools for chronic thromboembolic pulmonary hypertension: a step forward by the fatty acid-binding protein
Eur. Respir. J., May 1, 2008; 31(5): 915 - 917.
[Full Text] [PDF]


Home page
Eur Respir JHome page
M. Lankeit, C. Dellas, A. Panzenbock, N. Skoro-Sajer, D. Bonderman, M. Olschewski, K. Schafer, M. Puls, S. Konstantinides, and I. M. Lang
Heart-type fatty acid-binding protein for risk assessment of chronic thromboembolic pulmonary hypertension
Eur. Respir. J., May 1, 2008; 31(5): 1024 - 1029.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
H. J. Reesink, I. I. Tulevski, J. T. Marcus, F. Boomsma, J. J. Kloek, A. Vonk Noordegraaf, and P. Bresser
Brain Natriuretic Peptide as Noninvasive Marker of the Severity of Right Ventricular Dysfunction in Chronic Thromboembolic Pulmonary Hypertension
Ann. Thorac. Surg., August 1, 2007; 84(2): 537 - 543.
[Abstract] [Full Text] [PDF]


Home page
Proc Am Thorac SocHome page
E. Mayer and W. Klepetko
Techniques and Outcomes of Pulmonary Endarterectomy for Chronic Thromboembolic Pulmonary Hypertension
Proceedings of the ATS, September 1, 2006; 3(7): 589 - 593.
[Abstract] [Full Text] [PDF]


Home page
Proc Am Thorac SocHome page
L. J. Rubin, M. M. Hoeper, W. Klepetko, N. Galie, I. M. Lang, and G. Simonneau
Current and Future Management of Chronic Thromboembolic Pulmonary Hypertension: From Diagnosis to Treatment Responses
Proceedings of the ATS, September 1, 2006; 3(7): 601 - 607.
[Abstract] [Full Text] [PDF]


Home page
Proc Am Thorac SocHome page
A. Peacock, G. Simonneau, and L. Rubin
Controversies, Uncertainties and Future Research on the Treatment of Chronic Thromboembolic Pulmonary Hypertension
Proceedings of the ATS, September 1, 2006; 3(7): 608 - 614.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2006 by the American Thoracic Society.
 
ATS Quiz on Sleep Study Tracings